rs45617531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000817.3(GAD1):​c.-39A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000938 in 1,582,168 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00077 ( 5 hom. )

Consequence

GAD1
NM_000817.3 5_prime_UTR

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.40

Publications

1 publications found
Variant links:
Genes affected
GAD1 (HGNC:4092): (glutamate decarboxylase 1) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantigen and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Deficiency in this enzyme has been shown to lead to pyridoxine dependency with seizures. Alternative splicing of this gene results in two products, the predominant 67-kD form and a less-frequent 25-kD form. [provided by RefSeq, Jul 2008]
GAD1 Gene-Disease associations (from GenCC):
  • early infantile epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 89
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 1
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities
    Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-170818553-A-C is Benign according to our data. Variant chr2-170818553-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 893995.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00252 (383/152242) while in subpopulation AMR AF = 0.00549 (84/15290). AF 95% confidence interval is 0.00455. There are 2 homozygotes in GnomAd4. There are 189 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000817.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAD1
NM_000817.3
MANE Select
c.-39A>C
5_prime_UTR
Exon 2 of 17NP_000808.2Q99259-1
GAD1
NM_013445.4
c.-39A>C
5_prime_UTR
Exon 2 of 7NP_038473.2
GAD1-AS1
NR_197761.1
n.99T>G
non_coding_transcript_exon
Exon 1 of 4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAD1
ENST00000358196.8
TSL:1 MANE Select
c.-39A>C
5_prime_UTR
Exon 2 of 17ENSP00000350928.3Q99259-1
GAD1
ENST00000375272.5
TSL:1
c.-39A>C
5_prime_UTR
Exon 2 of 7ENSP00000364421.1Q99259-3
GAD1
ENST00000493875.5
TSL:1
n.-39A>C
non_coding_transcript_exon
Exon 1 of 17ENSP00000434696.1Q99259-4

Frequencies

GnomAD3 genomes
AF:
0.00252
AC:
384
AN:
152124
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00500
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00550
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00128
AC:
321
AN:
251020
AF XY:
0.00127
show subpopulations
Gnomad AFR exome
AF:
0.00561
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00517
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000739
Gnomad NFE exome
AF:
0.000706
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.000770
AC:
1101
AN:
1429926
Hom.:
5
Cov.:
26
AF XY:
0.000782
AC XY:
558
AN XY:
713590
show subpopulations
African (AFR)
AF:
0.00672
AC:
221
AN:
32872
American (AMR)
AF:
0.00175
AC:
78
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.00509
AC:
132
AN:
25924
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39508
South Asian (SAS)
AF:
0.00100
AC:
86
AN:
85640
European-Finnish (FIN)
AF:
0.000431
AC:
23
AN:
53388
Middle Eastern (MID)
AF:
0.00704
AC:
40
AN:
5682
European-Non Finnish (NFE)
AF:
0.000366
AC:
396
AN:
1082842
Other (OTH)
AF:
0.00209
AC:
124
AN:
59398
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
61
122
183
244
305
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00252
AC:
383
AN:
152242
Hom.:
2
Cov.:
31
AF XY:
0.00254
AC XY:
189
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.00496
AC:
206
AN:
41550
American (AMR)
AF:
0.00549
AC:
84
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00186
AC:
9
AN:
4826
European-Finnish (FIN)
AF:
0.000377
AC:
4
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000632
AC:
43
AN:
68002
Other (OTH)
AF:
0.00473
AC:
10
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00217
Hom.:
0
Bravo
AF:
0.00295
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
12
DANN
Benign
0.72
PhyloP100
1.4
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45617531; hg19: chr2-171675063; API